Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
4 injured in suburban Philadelphia nursing home explosion file negligence lawsuit - 2NASA says Maven spacecraft that was orbiting Mars has gone silent
- 3Katz, IDF: We assassinated IRGC intelligence chief Majid Khademi
- 4One perk to marrying Richard Marx later in life? 'We don't have time' for stupid arguments, says Daisy Fuentes.
- 54 Must-Visit bar-b-que Eateries This Year
- Addiction-stricken community struggles to keep a syringe program going after Trump's order
- Americans generally like wolves − except when we’re reminded of our politics
- This country music star spent years hiding his sexuality. Coming out — and beating addiction — has made his soul feel '20 pounds lighter.'
- The Response to Fake General Knowledge: Investigating the Eventual fate of artificial intelligence
- Email Promoting Instruments for Compelling Efforts
- General Atlantic says ‘biggest mistake’ would be pulling back on Gulf deals
- Three killed as unfinished building collapses on church service in Ghana
- Instructions to Safeguard Your Speculations In the midst of Changing Disc Rates
- Canada's Friendly Sunshine Coast City Is An Outdoor Playground Perfect For Hiking And Paddling
